End Stage Renal Disease study: Theranova Dialyzer
Official title An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
ClinicalTrials.gov ID: NCT06032208
What this study is testing
- What it's testing
- The study aims to find out whether a new dialyzer that removes larger waste molecules reduces the symptoms patients report during dialysis.
- Who it's for
- Adults with end‑stage renal disease who are receiving hemodialysis three times a week or less.
- What's involved
- Participants will use a new dialyzer during their regular dialysis sessions and record their symptoms each week using the LEVIL smartphone app.
- Time commitment
- The study lasts about 28 weeks and includes all regular dialysis visits plus weekly symptom reporting through the app.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Conventional thrice weekly HD schedule
- Must be on chronic hemodialysis for at least 3 months
- Age ≥18 years
- Willing and able to give informed consent
You likely can't join if
- Active infection (may enroll once infection is cleared)
- Patients receiving daily hemodialysis treatment
- Patients currently receiving Hemodiafiltration (HDF), Hemofiltration (HF) or Isolated ultrafiltration (ISO UF) more than once in three months
- Visual impairment
- History of neurocognitive impairment
- History of stroke (CVA)
The study team makes the final eligibility decision.
Where it is enrolling
- Winnipeg, Manitoba, Canada
- Halifax, Nova Scotia, Canada
- London, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Winnipeg, Manitoba, Canada; Halifax, Nova Scotia, Canada; London, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.